Medline, Inc. MDLN Amortization expense related to capitalized debt issuance costs
Amortization expense related to capitalized debt issuance costs at other companies
Other financials
Where this comes from
Reported directly by Medline, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.
The official record: Medline, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medline, Inc. 's amortization expense related to capitalized debt issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Medline, Inc. 's amortization expense related to capitalized debt issuance costs?
- Medline, Inc. (MDLN) reported amortization expense related to capitalized debt issuance costs of $11M in Q1 2026.
- How has Medline, Inc. 's amortization expense related to capitalized debt issuance costs changed year-over-year?
- Medline, Inc. 's amortization expense related to capitalized debt issuance costs decreased by 26.7% year-over-year, from $15M to $11M.